Gary Sphar is CFO & Mylan Pharmaceuticals Inc at MYLAN LABORATORIES INC (MYL). They have made 1 open-market trade across 1 company since 2006, most recently 2006-09-15.
CIK 0001197550
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYL | 13,145 | $208K |
Shares reported on the most recent Form 4, priced at the 2006-09-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYL | SELL | 2006-09-15 | 2006-09-19 | $21.20 | $172K | -7.5% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.